nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A functional −77T>C polymorphism in XRCC1 is associated with risk of breast cancer
|
Liu, Li |
|
2010 |
125 |
2 |
p. 479-487 |
artikel |
2 |
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
|
Donenberg, Talia |
|
2010 |
125 |
2 |
p. 591-596 |
artikel |
3 |
Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis
|
Lu, Pei-Hua |
|
2010 |
125 |
2 |
p. 537-543 |
artikel |
4 |
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
|
Blum, Joanne L. |
|
2010 |
125 |
2 |
p. 431-439 |
artikel |
5 |
Cadmium concentration in biological media of breast cancer patients
|
Strumylaite, Loreta |
|
2010 |
125 |
2 |
p. 511-517 |
artikel |
6 |
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
|
Reijm, E. A. |
|
2010 |
125 |
2 |
p. 387-394 |
artikel |
7 |
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
|
Pollari, Sirkku |
|
2010 |
125 |
2 |
p. 421-430 |
artikel |
8 |
Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis
|
Yuan, Weiguang |
|
2010 |
125 |
2 |
p. 467-472 |
artikel |
9 |
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
|
Wilking, Ulla |
|
2010 |
125 |
2 |
p. 553-561 |
artikel |
10 |
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer
|
Met, Özcan |
|
2010 |
125 |
2 |
p. 395-406 |
artikel |
11 |
Individual responses to chemotherapy-induced oxidative stress
|
Il’yasova, Dora |
|
2010 |
125 |
2 |
p. 583-589 |
artikel |
12 |
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls
|
Ding, Hong |
|
2010 |
125 |
2 |
p. 473-477 |
artikel |
13 |
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility was not credible: appraisal of a recent meta-analysis
|
Lu, Pei-Hua |
|
2010 |
125 |
2 |
p. 597-598 |
artikel |
14 |
Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
|
Sluiter, Michelle D. |
|
2010 |
125 |
2 |
p. 325-349 |
artikel |
15 |
Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk
|
Lu, Pei-Hua |
|
2010 |
125 |
2 |
p. 599-600 |
artikel |
16 |
No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk
|
Lu, Pei-Hua |
|
2010 |
125 |
2 |
p. 601-603 |
artikel |
17 |
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
|
Jerusalem, Guy |
|
2010 |
125 |
2 |
p. 447-455 |
artikel |
18 |
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk
|
Justenhoven, Christina |
|
2010 |
125 |
2 |
p. 563-569 |
artikel |
19 |
Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial
|
Chen, Yun |
|
2010 |
125 |
2 |
p. 495-504 |
artikel |
20 |
Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen
|
Siegelmann-Danieli, Nava |
|
2010 |
125 |
2 |
p. 505-510 |
artikel |
21 |
RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis
|
Zhou, Guo-Wu |
|
2010 |
125 |
2 |
p. 529-535 |
artikel |
22 |
Relationship between diabetes and risk of second primary contralateral breast cancer
|
Li, Christopher I. |
|
2010 |
125 |
2 |
p. 545-551 |
artikel |
23 |
Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China
|
Chen, Xiao-Hui |
|
2010 |
125 |
2 |
p. 575-582 |
artikel |
24 |
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review
|
Pepels, Manon J. |
|
2010 |
125 |
2 |
p. 301-313 |
artikel |
25 |
Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies
|
Dong, Jia-Yi |
|
2010 |
125 |
2 |
p. 315-323 |
artikel |
26 |
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of 131I by carbamazepine in breast cancer cells
|
Willhauck, Michael J. |
|
2010 |
125 |
2 |
p. 377-386 |
artikel |
27 |
Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
|
Liang, Yayun |
|
2010 |
125 |
2 |
p. 407-420 |
artikel |
28 |
The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
|
Shi, Ming |
|
2010 |
125 |
2 |
p. 351-362 |
artikel |
29 |
The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis
|
Gao, Lin-Bo |
|
2010 |
125 |
2 |
p. 571-574 |
artikel |
30 |
The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
|
Londen, G. J. van |
|
2010 |
125 |
2 |
p. 441-446 |
artikel |
31 |
The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation
|
Yao, Hongren |
|
2010 |
125 |
2 |
p. 363-375 |
artikel |
32 |
Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer
|
Linderholm, Barbro K. |
|
2010 |
125 |
2 |
p. 457-465 |
artikel |
33 |
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study
|
Thomson, Cynthia A. |
|
2010 |
125 |
2 |
p. 519-527 |
artikel |
34 |
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls
|
Gu, Dongying |
|
2010 |
125 |
2 |
p. 489-493 |
artikel |